Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,200
Out of 4,786 analysts
46
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $13.22 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $61.77 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $262.61 | +21.85% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $89.86 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $32.26 | +48.79% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $166.60 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $0.40 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $104.68 | -23.58% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $9.49 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $43.29 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $132.65 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.70 | - | 1 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $100.88 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $68.29 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $72.48 | - | 4 | Feb 2, 2017 | |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.22
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $61.77
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $262.61
Upside: +21.85%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $89.86
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $32.26
Upside: +48.79%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $166.60
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $104.68
Upside: -23.58%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $9.49
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $43.29
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $132.65
Upside: -
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $0.70
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $100.88
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $68.29
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $72.48
Upside: -